HRL vs LIXT · P/E 29, rev $8.96B vs $121.0M cap
Hormel Foods Corporation (HRL) versus Lixte Biotechnology Holdings Inc (LIXT) — a side-by-side from cached financials, not a winner call.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Lixte Biotechnology Holdings Inc (LIXT) is a biotechnology company listed on NASDAQ.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
LIXT does not have a complete income-statement cache yet.
HRL currently screens at market cap $13.39B and trailing P/E 28.6. LIXT currently screens at market cap $121.0M.
Not investment advice. Open the HRL and LIXT stock pages for the full models.
Not investment advice.